A closer look at the health financing situation reveals some trends that can be a cause for concern if not addressed in due time, for example, while significant funds flow into curative care, not much information is available on quality of care and value for money spent on different interventions. This situation led the Ministry of Finance to request an analysis of pharmaceutical policies, with the objective of identifying options for improving value...
Voir la suite
INFORMATION
-
2020/05/01
-
Rapport
-
150130
-
1
-
1
-
2020/06/28
-
Disclosed
-
Croatia - Value for Money in Spending on Pharmaceuticals : Draft Policy Note
-
Medicine